1. Home
  2. PRAX vs TKR Comparison

PRAX vs TKR Comparison

Compare PRAX & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$318.23

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Timken Company (The)

TKR

Timken Company (The)

HOLD

Current Price

$140.33

Market Cap

9.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
TKR
Founded
2015
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
9.2B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
TKR
Price
$318.23
$140.33
Analyst Decision
Strong Buy
Buy
Analyst Count
15
7
Target Price
$572.13
$118.29
AVG Volume (30 Days)
560.5K
1.0M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
1.31%
EPS Growth
N/A
N/A
EPS
N/A
1.40
Revenue
N/A
$80,100,000.00
Revenue This Year
N/A
$4.57
Revenue Next Year
$7,758.26
$3.97
P/E Ratio
N/A
$102.87
Revenue Growth
N/A
N/A
52 Week Low
$37.25
$70.79
52 Week High
$366.52
$145.61

Technical Indicators

Market Signals
Indicator
PRAX
TKR
Relative Strength Index (RSI) 57.49 61.31
Support Level $308.40 $105.06
Resistance Level $327.65 N/A
Average True Range (ATR) 17.85 4.44
MACD 8.65 -0.41
Stochastic Oscillator 83.99 59.95

Price Performance

Historical Comparison
PRAX
TKR

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The various products offered by the company include ball bearings, plain bearings, tapered roller bearings, housed bearings, linear guides, telescopic rails, lubrication systems, agricultural conveyor chains, couplings, brakes, seals, etc. These products are offered through brands like Timken, GGB, Philadelphia Gear, Cone Drive, CGI, and Rollon, among others. The company has two reportable segments: Engineered Bearings, which generates the maximum revenue, and Industrial Motion. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Africa (EMEA), Asia-Pacific, and the other regions of the Americas.

Share on Social Networks: